Why the study?
The contribution of short-term glycemic variability (within-day and between-day glycemic oscillations) to diabetic complications remains an enigma.
Does short-term glycemic variability contribute to microvascular and macrovascular complications in patients with diabetes?
Does short-term glycemic variability contribute to microvascular and macrovascular complications in patients with diabetes?
Answers are grounded in this paper and cite their sources.
Short-term glycemic variability is an emerging metric that may be associated with microvascular and macrovascular complications in patients with diabetes.
The introduction of continuous glucose monitoring inaugurated a new era in clinical practice by shifting the characterization of glycemic control from HbA1c to novel metrics. The one that gained widespread attention over the past decades was glycemic variability (GV), which typically refers to peaks and nadirs of blood glucose measured over a given time interval. GV can be dichotomized into two main categories: short-term and long-term. Short-term GV reflects within-day and between-day glycemic oscillations, and its contribution to diabetic complications remains an enigma. In this review, we summarize the available data about short-term GV and its possible association with both microvascular and macrovascular complications, evaluating different pathogenic mechanisms and demonstrating nonpharmaceutical, as well as pharmaceutical, therapeutic interventions.
No takes yet. Share an insight, caveat, or question.
Psoma et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: